BI Asks Tennessee Contract Pharmacies to Report Claims Data Ahead of New State Law, BMS Updates Contract Pharmacy Restrictions

Boehringer Ingelheim announced new 340B claims data requirements for Tennessee covered entities.
Tennessee covered entities must now submit claims data for all Boehringer Ingelheim (BI) 340B drugs filled by their in-house pharmacies [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Vermont House Modifies 340B Contract Pharmacy Access and Hospital Reporting Bill, Hospital Advocates Voice Concerns About Changes

Vermont House lawmakers voted Friday to approve an amended contract pharmacy access bill, which includes price caps on some hospitals that has raised concerns from some state health systems.
The Vermont House on Friday approved a 340B contract pharmacy access bill with Senate-backed hospital reporting requirements and a new [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

In Novel Approach, Vertex to Automatically Exempt States from 340B Contract Pharmacy Restrictions as New Laws Take Effect and Apply Exemptions Liberally; Other Companies Exempt Additional States 

Multiple drugmakers announced exemptions to contract pharmacy restrictions recently, including Vertex, which will automatically exempt states that enact contract pharmacy access laws moving forward.
Four drugmakers recently announced they will exempt additional states from their 340B contract pharmacy restrictions in response to a flurry [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Contract Pharmacy Lawsuit Roundup: Key Briefs Filed in Nebraska, South Dakota and 5th Circuit

Key briefs were filed recently in Nebraska, South Dakota and the 5th Circuit.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Sumitomo Exempts Four More States From 340B Contract Pharmacy Restrictions, GSK Exempts Nebraska, Utah

Sumitomo Pharma America has announced exemptions to its contract pharmacy restrictions for 340B covered entities in Nebraska, North Dakota, South Dakota and Utah.
Two major drug manufacturers are loosening their 340B contract pharmacy restrictions for states that have passed contract pharmacy access laws [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Roundup: 5th Circuit Appeals in Louisiana, 4th Circuit Appeal in West Virginia 

Key briefs were filed recently in state contract pharmacy litigation in West Virginia and Louisiana.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Merck is First to Exempt South Dakota from 340B Contract Pharmacy Restrictions but Reinstates in Kansas, Novartis Exempts Missouri 

Merck announced it will exempt South Dakota from its contract pharmacy restrictions and reinstate them in Kansas. Novartis will exempt Missouri from its contract pharmacy restrictions.
Drugmakers Merck and Novartis recently updated their 340B contract pharmacy restrictions, modifying what states are exempt from such policies following [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Advocate Slams Federal ‘No 340B Savings for Transgender Care Act’ Proposal

Peggy Tighe, a principal at Powers Law, told 340B Report that U.S. Rep. Dusty Johnson’s (R-S.D.) bill "appears to be an attempt to thwart attacks against the 340B program, perhaps to protect GOP state and federal legislators, but it is anti-states' rights and an overreaction to a false and incendiary campaign.”
A 340B program advocate this week condemned a new GOP U.S. House bill that would prohibit covered entities from using [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Misinformation Makes Up Small Part of 340B Conversations Online, But Garners Outsized Attention, Analysis Finds

Storyful Rx analyzed more than 6,000 social media posts and articles mentioning the 340B program between Aug. 11, 2024 and Feb. 11, 2025.
Although misinformation accounts for just 2% of the overall 340B conversations taking place online, “conspiratorial narratives” driven by conservative influencers—and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Recap of Recent Webinar: A Closer Look at Battles Over State 340B Contract Pharmacy Access Bills and Laws

340B Report's latest webinar overviewed contract pharmacy developments in state legislatures and the courts, plus how a dark money group has ramped up anti-340B ads.
As state legislatures ramp up efforts to protect contract pharmacy access, drug industry lawsuits against existing state laws continue to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live